3World Health Organization. Cumulative Number of Confirmed Human Cases of Avian Influenza A/( HSN1 ) Reported to WHO [ DB/OL]. [ 2009-02-27 ]. http://www. who. int/csr/disease/ avian_influenza/country/cases table_2009_02_27/en/index. html.
4World Health Organization. Clinical management of human infection with avian influenza A ( HSN1 ) virus. 15 August 2007 [ DB/OL]. [ 2009-04-16 ]. http://www.who. int/csr/disease/ avian_influenza/guidelines/clinicalmanage07/en/index. html.
5Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A ( H5N1 ) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, et al. Update on avian influenza A ( HSN1 ) virus infection in humans. N Engl J Med, 2008,358:261-273.
6World Health Organization. WHO Rapid Advice Guidelines on pharmacological management of humans infected with avian influenza A (HSN1) virus. May 2006. [ DB/OL]. [2009-04- 16 ]. http://www. who. int/csr/disease/avian _ influenza/ guidelines/pharmamanagement/en/index.html.
7Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids : the Guangzhou experience. Chest, 2006,129 : 1441-1452.
8Lu J, Guo Z, Pan X, et al. Passive immunotherapy for influenza A H5N1 virus infection with equine hypefimmune globulin F (ab')2 in mice. Respir Res, 2006,7:43.
9Hanson BJ, Boon AC, Lim AP, et al. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respir Res, 2006,7:126.
10Simmons CP, Bernasconi NL, Suguitan AL, et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med, 2007,4:e178.
